SPRC MEXC RealStocks
Own real SPRC shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 04:00:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
SciSparc Ltd. (SPRC) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.28, with a market capitalization of $814.66K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.24 to $29.88. This page covers its latest market performance, valuation, price trends and company information.
$814.66K | |
$0.36 | |
$0.45 | |
$0.24 | |
$0.33 | |
14.53M | |
1.37M | |
-- | |
$29.88 | |
$0.24 | |
-- | |
2026-06-30 |
SciSparc Ltd. (SPRC) last closed at $0.28 as of 2026-11-19 01:00:00, down 16.59% ($0.05) from the previous close of $0.33.
During the latest regular trading session, SPRC traded between $0.24 and $0.45, with a volume of 14.53M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, SciSparc Ltd. (SPRC) moved from $0.42 to $0.28, representing a decline of 33.57% ($0.14).
The stock traded between $0.24 and $0.45 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 119.98 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
SPRC is currently trading at $0.28, placing it 0.1% of the way from its 52-week low of $0.24 to its 52-week high of $29.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
| Employees | 3 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SciSparc Ltd. (SPRC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SPRC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SPRC shares and USD.
SPRC Shares to USD
1.00 SPRC shares = 0.276 USD
Calculations are estimates based on the latest available price and are for reference only.